Stocks News

LAST PRICE
163.5900
TODAY'S CHANGE (%)
Trending Up6.3400 (4.0318%)

Bid / Lots
163.3500/ 4
Ask / Lots
164.0500/ 4
Open / Previous Close
157.9200 / 157.2500
Day Range
Low 157.9200
High 164.7300
52 Week Range
Low 82.0900
High 189.9700
Volume
126,815
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- DJ Krystal Biotech Price Target Maintained With a $200.00/Share by HC Wainwright & Co., from 1:58PM ET on Monday Apr 22, 2024 by Dow Jones
  1:58PM ET on Monday Apr 22, 2024 by Dow Jones
  Companies Mentioned: KRYS
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/KRYS/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 22, 2024 13:58 ET (17:58 GMT)
- Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung, from 7:00AM ET on Monday Apr 22, 2024 by GlobeNewswire
  7:00AM ET on Monday Apr 22, 2024 by GlobeNewswire
  Companies Mentioned: KRYS
- Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung, from 7:00AM ET on Monday Apr 22, 2024 by Dow Jones
  7:00AM ET on Monday Apr 22, 2024 by Dow Jones
  Companies Mentioned: KRYS
  
  Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung
  
  -- Received Fast Track Designations for both inhaled and intratumoral KB707
Apr 16, 2024
- Stifel Adjusts Price Target on Krystal Biotech to $204 From $178, Maintains Buy Rating, from 9:12AM ET on Tuesday Apr 16, 2024 by MT Newswires
  9:12AM ET on Tuesday Apr 16, 2024 by MT Newswires
  Companies Mentioned: KRYS
  09:12 AM EDT, 04/16/2024 (MT Newswires) -- Krystal Biotech (KRYS) has an average buy rating and a price target range of $153 to $208, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from major...
- DJ Krystal Biotech Price Target Raised to $204.00/Share From $178.00 by Stifel, from 8:33AM ET on Tuesday Apr 16, 2024 by Dow Jones
  8:33AM ET on Tuesday Apr 16, 2024 by Dow Jones
  Companies Mentioned: KRYS
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/KRYS/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 16, 2024 08:33 ET (12:33 GMT)

Today
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AIRC, ALPN, WIRE, from 3 hours ago by PR Newswire
  3 hours ago by PR Newswire
  Companies Mentioned: WIRE, AIRC, ALPN
- Madrigal Pharmaceuticals to Release First-Quarter 2024 Financial Results and Host Webcast on May 7, 2024, from 7 hours ago by GlobeNewswire
  7 hours ago by GlobeNewswire
  Companies Mentioned: MDGL
Yesterday
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALPN, LABP, SWAV, FUSN, from 20 hours ago by Accesswire
  20 hours ago by Accesswire
  Companies Mentioned: SWAV, FUSN, LABP, ALPN
- TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUSN, from 22 hours ago by GlobeNewswire
  22 hours ago by GlobeNewswire
  Companies Mentioned: SWAV, FUSN, LABP, ALPN
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INRD, AIRC, ELYM, ALPN, from 11:13AM ET on Monday Apr 22, 2024 by GlobeNewswire
  11:13AM ET on Monday Apr 22, 2024 by GlobeNewswire
  Companies Mentioned: AIRC, ELYM, ALPN
- Kuehn Law Encourages INRD, AIRC, ELYM, and ALPN Investors to Contact Law Firm, from 9:48AM ET on Monday Apr 22, 2024 by GlobeNewswire
  9:48AM ET on Monday Apr 22, 2024 by GlobeNewswire
  Companies Mentioned: AIRC, ELYM, ALPN
- --BofA Securities Initiates Coverage of Madrigal Pharmaceuticals with Underperform Rating, $150 Price Objective, from 9:46AM ET on Monday Apr 22, 2024 by MT Newswires
  9:46AM ET on Monday Apr 22, 2024 by MT Newswires
  Companies Mentioned: MDGL
- --BofA Securities Starts Madrigal Pharmaceuticals With Underperform Rating, $150 Price Target, from 8:41AM ET on Monday Apr 22, 2024 by MT Newswires
  8:41AM ET on Monday Apr 22, 2024 by MT Newswires
  Companies Mentioned: MDGL
Apr 20, 2024
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ADTH, MODN, ALPN, from 11:16AM ET on Saturday Apr 20, 2024 by GlobeNewswire
  11:16AM ET on Saturday Apr 20, 2024 by GlobeNewswire
  Companies Mentioned: MODN, ADTH, ALPN
Apr 19, 2024
- Immunovant Insider Sold Shares Worth $990,269, According to a Recent SEC Filing, from 6:01PM ET on Friday Apr 19, 2024 by MT Newswires
  6:01PM ET on Friday Apr 19, 2024 by MT Newswires
  Companies Mentioned: IMVT

Krystal Biotech Inc
NASDAQ:KRYSUnited States

Search Criteria

Yesterday

DJ Krystal Biotech Price Target Maintained With a $200.00/Share by HC Wainwright & Co., from 1:58PM ET on Monday Apr 22, 2024 by Dow Jones

Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung, from 7:00AM ET on Monday Apr 22, 2024 by GlobeNewswire

Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung, from 7:00AM ET on Monday Apr 22, 2024 by Dow Jones

Apr 16, 2024

Stifel Adjusts Price Target on Krystal Biotech to $204 From $178, Maintains Buy Rating, from 9:12AM ET on Tuesday Apr 16, 2024 by MT Newswires

DJ Krystal Biotech Price Target Raised to $204.00/Share From $178.00 by Stifel, from 8:33AM ET on Tuesday Apr 16, 2024 by Dow Jones

Peers Headlines

Today

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AIRC, ALPN, WIRE, from 3 hours ago by PR Newswire

Madrigal Pharmaceuticals to Release First-Quarter 2024 Financial Results and Host Webcast on May 7, 2024, from 7 hours ago by GlobeNewswire

Yesterday

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALPN, LABP, SWAV, FUSN, from 20 hours ago by Accesswire

TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUSN, from 22 hours ago by GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INRD, AIRC, ELYM, ALPN, from 11:13AM ET on Monday Apr 22, 2024 by GlobeNewswire

Kuehn Law Encourages INRD, AIRC, ELYM, and ALPN Investors to Contact Law Firm, from 9:48AM ET on Monday Apr 22, 2024 by GlobeNewswire

--BofA Securities Initiates Coverage of Madrigal Pharmaceuticals with Underperform Rating, $150 Price Objective, from 9:46AM ET on Monday Apr 22, 2024 by MT Newswires

--BofA Securities Starts Madrigal Pharmaceuticals With Underperform Rating, $150 Price Target, from 8:41AM ET on Monday Apr 22, 2024 by MT Newswires

Apr 20, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ADTH, MODN, ALPN, from 11:16AM ET on Saturday Apr 20, 2024 by GlobeNewswire

Apr 19, 2024

Immunovant Insider Sold Shares Worth $990,269, According to a Recent SEC Filing, from 6:01PM ET on Friday Apr 19, 2024 by MT Newswires